{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:35:04Z","timestamp":1792067704939,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejps.2026.107496","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:27:10Z","timestamp":1772846830000},"page":"107496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["LeiCNS-PK3.2: A physiologically based pharmacokinetic model framework for predicting intracellular concentrations of acyclovir and ganciclovir active metabolites"],"prefix":"10.1016","volume":"221","author":[{"given":"Ming","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn L.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-1152","authenticated-orcid":false,"given":"Tingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8303-1117","authenticated-orcid":false,"given":"Elizabeth C.M.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107496_bib0001","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of Human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107496_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jcp.1041320117","article-title":"Proliferative potential of human fibroblasts: an inverse dependence on cell size","volume":"132","author":"Angello","year":"1987","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejps.2026.107496_bib0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12987-025-00726-w","article-title":"Comparative analysis of the uptake of the H(+)\/OC antiporter substrate oxycodone across and into brain endothelial and parenchymal cells with in vitro-in vivo extrapolation","volume":"22","author":"B\u00e4llgren","year":"2025","journal-title":"Fluids. Barriers. CNS."},{"key":"10.1016\/j.ejps.2026.107496_bib0004","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00381-008-0590-z","article-title":"Mycoplasma meningitis resulting in increased production of cerebrospinal fluid: case report and review of the literature","volume":"24","author":"Bauer","year":"2008","journal-title":"Child's Nerv. Syst.: ChNS: Off. J. Int. Soc. Pediatr. Neurosurg."},{"key":"10.1016\/j.ejps.2026.107496_bib0005","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1073\/pnas.93.8.3525","article-title":"Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy","volume":"93","author":"Black","year":"1996","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2026.107496_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.575","article-title":"Applicability of free drug hypothesis to drugs with good membrane permeability that are not efflux transporter substrates: a microdialysis study in rats","volume":"8","author":"Chen","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejps.2026.107496_bib0007","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00010.2003","article-title":"Regulation and modulation of pH in the brain","volume":"83","author":"Chesler","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejps.2026.107496_bib0008","article-title":"Pathogenesis of virus infections","author":"CJ","year":"2017","journal-title":"Fenner White's Med. Virol."},{"key":"10.1016\/j.ejps.2026.107496_bib0009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2184.2010.00702.x","article-title":"Ion channels in volume regulation of clonal kidney cells","volume":"43","author":"da Silva","year":"2010","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejps.2026.107496_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-8118-10-12","article-title":"The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects","volume":"10","author":"de Lange","year":"2013","journal-title":"Fluids. Barriers. CNS."},{"key":"10.1016\/j.ejps.2026.107496_bib0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cpt.2545","article-title":"Understanding the blood-brain barrier and beyond: challenges and opportunities for novel CNS therapeutics","volume":"111","author":"de Lange","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107496_bib0012","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1124\/dmd.111.038778","article-title":"Species independence in brain tissue binding using brain homogenates","volume":"39","author":"Di","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107496_bib0013","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-022-02538-3","article-title":"Spatial and temporal variation of routine parameters: pitfalls in the cerebrospinal fluid analysis in central nervous system infections","volume":"19","author":"Djukic","year":"2022","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.ejps.2026.107496_bib0014","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/geronj\/30.6.647","article-title":"Rat brain fatty acid composition: effect of dietary fat and age","volume":"30","author":"Eddy","year":"1975","journal-title":"J. Gerontol."},{"key":"10.1016\/j.ejps.2026.107496_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/clpt.1986.177","article-title":"Human pharmacokinetics of the antiviral drug DHPG","volume":"40","author":"Fletcher","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107496_bib0016","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/dmd.108.026377","article-title":"Development of a high-throughput brain slice method for studying drug distribution in the central nervous system","volume":"37","author":"Frid\u00e9n","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107496_bib0017","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.20.4.518","article-title":"Metabolism of acyclovir in virus-infected and uninfected cells","volume":"20","author":"Furman","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0018","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1128\/AAC.02311-13","article-title":"Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells","volume":"58","author":"Gentry","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0019","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0020","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1128\/JVI.00516-14","article-title":"Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells","volume":"88","author":"Harkness","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2026.107496_bib0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/psp4.12537","article-title":"Predictions of systemic, intracellular, and lung concentrations of azithromycin with different dosing regimens used in COVID-19 clinical trials","volume":"9","author":"Hughes","year":"2020","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107496_bib0022","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8454-5-10","article-title":"Multiplicity of cerebrospinal fluid functions: new challenges in health and disease","volume":"5","author":"Johanson","year":"2008","journal-title":"CerebroSpinal Fluid. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0023","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1021\/acs.jmedchem.3c00481","article-title":"DruMAP: a novel drug metabolism and pharmacokinetics analysis platform","volume":"66","author":"Kawashima","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2026.107496_bib0024","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1208\/s12248-014-9625-4","article-title":"Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain","volume":"16","author":"Kervezee","year":"2014","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2026.107496_bib0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0090-9556(25)07149-1","article-title":"Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat","volume":"19","author":"Khor","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107496_bib0026","first-page":"E613","article-title":"Comparison of intrathecal concentrations of acyclovir following epidural and intravenous administration in rats","volume":"19","author":"Kim","year":"2016","journal-title":"Pain. Physician"},{"key":"10.1016\/j.ejps.2026.107496_bib0027","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1110\/ps.2460102","article-title":"Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity","volume":"11","author":"Kokoris","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2026.107496_bib0028","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0031-6997(24)01513-8","article-title":"Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations","volume":"53","author":"Lee","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2026.107496_bib0029","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/13892002113149990002","article-title":"Systematic evaluation of dose accumulation studies in clinical pharmacokinetics","volume":"14","author":"Li","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2026.107496_bib0030","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/dmd.108.024125","article-title":"Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107496_bib0031","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-8118-10-6","article-title":"The brain slice method for studying drug distribution in the CNS","volume":"10","author":"Loryan","year":"2013","journal-title":"Fluids. Barriers. CNS."},{"key":"10.1016\/j.ejps.2026.107496_bib0032","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11095-022-03246-6","article-title":"Unbound brain-to-plasma partition coefficient, K(p,uu,brain)-a game changing parameter for CNS drug discovery and development","volume":"39","author":"Loryan","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0033","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s11095-022-03246-6","article-title":"Unbound brain-to-plasma partition coefficient, kp,uu,brain\u2014a game changing parameter for CNS drug discovery and development","volume":"39","author":"Loryan","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0034","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s11095-014-1319-1","article-title":"Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery","volume":"31","author":"Loryan","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0035","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","article-title":"Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir","volume":"47","author":"Lycke","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0036","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbamem.2017.02.011","article-title":"Lipid mapping of the rat brain for models of disease","volume":"1859","author":"Mart\u00ednez-Gardeazabal","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2026.107496_bib0037","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejps.2026.107496_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207694","article-title":"Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study","volume":"2015","author":"Peredo","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ejps.2026.107496_bib0039","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/jac\/dkab135","article-title":"Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5\u2032-triphosphate exposure to support posology for SARS-CoV-2","volume":"76","author":"Pertinez","year":"2021","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.ejps.2026.107496_bib0040","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0041","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1128\/AAC.01023-10","article-title":"Valacyclovir for herpes simplex encephalitis","volume":"55","author":"Pouplin","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0042","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/cpt.2198","article-title":"Model-informed drug development for anti-infectives: state of the art and future","volume":"109","author":"Rayner","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107496_bib0043","article-title":"The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells","volume":"181","author":"Saleh","year":"2023","journal-title":"Eur J. Pharm Sci. Off J. Eur. Fed. Pharm Sci."},{"key":"10.1016\/j.ejps.2026.107496_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106345","article-title":"The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells","volume":"181","author":"Saleh","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107496_bib0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10928-021-09768-7","article-title":"Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations","volume":"48","author":"Saleh","year":"2021","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2026.107496_bib0046","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10928-021-09768-7","article-title":"Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations","volume":"48","author":"Saleh","year":"2021","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2026.107496_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104713","article-title":"Biosynthesis and half-life of MBX-2168-triphosphate in herpes virus-infected cells","volume":"175","author":"Sauer","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0048","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(00)02893-6","article-title":"Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study","volume":"884","author":"Scism","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0049","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13318-021-00733-w","article-title":"Acyclovir brain disposition: interactions with P-gp, bcrp, Mrp2, and Oat3 at the blood-brain barrier","volume":"47","author":"Shan","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107496_bib0050","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/AAC.00729-09","article-title":"Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function","volume":"54","author":"Smith","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0051","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/AAC.00729-09","article-title":"Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function","volume":"54","author":"Smith","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0052","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp.2007.129098","article-title":"Viral encephalitis: a clinician's guide","volume":"7","author":"Solomon","year":"2007","journal-title":"Pr. Neurol."},{"key":"10.1016\/j.ejps.2026.107496_bib0053","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","article-title":"Absolute bioavailability and metabolic disposition of valaciclovir, the l-valyl ester of acyclovir, following oral administration to humans","volume":"39","author":"Soul-Lawton","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2026.107496_bib0054","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40263-024-01082-3","article-title":"CNS viral infections-what to consider for improving drug treatment: a plea for using mathematical modeling approaches","volume":"38","author":"Sun","year":"2024","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.ejps.2026.107496_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-025-01545-w","article-title":"Revisiting acyclovir dosing for adult viral encephalitis using a full bayesian LeiCNS PBPK modeling approach","author":"Sun","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107496_bib0056","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12248-011-9318-1","article-title":"Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate","volume":"14","author":"Syv\u00e4nen","year":"2012","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2026.107496_bib0057","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1111\/bcp.15310","article-title":"Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women","volume":"88","author":"Tanaudommongkon","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107496_bib0058","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00701-023-05650-2","article-title":"Cerebrospinal fluid production rate in various pathological conditions: a preliminary study","volume":"165","author":"Tariq","year":"2023","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.ejps.2026.107496_bib0059","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2026.107496_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-019-0133-x","article-title":"The need for mathematical modelling of spatial drug distribution within the brain","volume":"16","author":"Vendel","year":"2019","journal-title":"Fluids. Barriers. CNS."},{"key":"10.1016\/j.ejps.2026.107496_bib0061","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1023\/A:1016092525901","article-title":"The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach","volume":"13","author":"Wang","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107496_bib0062","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1208\/s12248-017-0050-3","article-title":"Microdialysis: the key to physiologically based model prediction of Human CNS target site concentrations","volume":"19","author":"Yamamoto","year":"2017","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2026.107496_bib0063","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/psp4.12250","article-title":"Predicting drug concentration-time profiles in multiple CNS compartments using a comprehensive physiologically-based pharmacokinetic model","volume":"6","author":"Yamamoto","year":"2017","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107496_bib0064","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17425255.2022.2112175","article-title":"Important roles of transporters in the pharmacokinetics of anti-viral nucleoside\/nucleotide analogs","volume":"18","author":"Yang","year":"2022","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2026.107496_bib0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1124\/dmd.119.086744","article-title":"Drug concentration asymmetry in tissues and plasma for small molecule-related therapeutic modalities","volume":"47","author":"Zhang","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2026.107496_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106883","article-title":"Exploring Kp,uu,BBB values smaller than unity in remoxipride: a physiologically-based CNS model approach highlighting brain metabolism in drugs with passive blood-brain barrier transport","volume":"203","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharm. Sci: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107496_bib0067","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0197-4580(96)00076-0","article-title":"The lipid compositions of different regions of rat brain during development and aging","volume":"17","author":"Zhang","year":"1996","journal-title":"Neurobiol. Aging"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:53:22Z","timestamp":1779710002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"alternative-id":["S0928098726000709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107496","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LeiCNS-PK3.2: A physiologically based pharmacokinetic model framework for predicting intracellular concentrations of acyclovir and ganciclovir active metabolites","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107496"}}